Literature DB >> 27595506

Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer.

S Komatsu1, D Ichikawa2, M Nishimura2, T Kosuga2, K Okamoto2, H Konishi2, A Shiozaki2, H Fujiwara2, E Otsuji2.   

Abstract

AIMS: To detect the best cut-off value of the positive lymph node ratio (PLNR) for stratifying the prognosis and analyzing its value with regard to stage migration effect using PLNR in gastric cancer.
METHODS: We retrospectively analyzed 1069 consecutive gastric cancer patients, who underwent curative gastrectomy with radical lymphadenectomy from 1997 through 2009.
RESULTS: 1) The mean number of dissected lymph nodes was 42.6 in pStage I, 32.4 in pStage II and 37.1 in pStage III. The PLNR of 0.2 was proved to be the best cut-off value to stratify the prognosis of patients into two groups (P < 0.0001; PLNR <0.2 vs. PLNR ≥0.2), and patients were correctly classified into four groups: PLNR 0, PLNR 0-<0.2, PLNR 0.2-<0.4 and PLNR ≥0.4 by the Kaplan-Meier method. 2) Compared patients with the PLNR <0.2, those with the PLNR ≥0.2 had a significantly higher incidence of pT3 or greater, pN2 or greater, lymphatic invasion, vascular invasion and undifferentiated cancer. Multivariate analysis showed that the PLNR ≥0.2 was an independent prognostic factor [P < 0.0001, HR 2.77 (95% CI: 1.87-4.09)]. 2) The PLNR cut-off value of 0.2 could discriminate a stage migration effect in pN2-N3 and pStage II-III, which patients with PLNR ≥0.2 might be potentially diagnosed as a lower stage after gastrectomy.
CONCLUSION: The PLNR contributes to evaluating prognosis and stage migration effect even in a single institute and enable to identify those who need meticulous treatments and follow-up in patients with gastric cancer.
Copyright © 2016 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Gastric cancer; Lymph node metastasis; Positive lymph node ratio; Prognosis; Stage migration

Mesh:

Year:  2016        PMID: 27595506     DOI: 10.1016/j.ejso.2016.08.002

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

Review 1.  Prognostic impact of nodal status and therapeutic implications.

Authors:  Katja Ott; Susanne Blank; Laura Ruspi; Margit Bauer; Leila Sisic; Thomas Schmidt
Journal:  Transl Gastroenterol Hepatol       Date:  2017-03-15

2.  The association of the lymph node ratio and serum carbohydrate antigen 19-9 with early recurrence after curative gastrectomy for gastric cancer.

Authors:  Hiroshi Sawayama; Masaaki Iwatsuki; Daisuke Kuroda; Tasuku Toihata; Tomoyuki Uchihara; Yuki Koga; Taisuke Yagi; Yuki Kiyozumi; Tsugio Eto; Yukiharu Hiyoshi; Takatsugu Ishimoto; Yoshifumi Baba; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Surg Today       Date:  2018-06-20       Impact factor: 2.549

3.  Gastrectomy with D2 Lymphadenectomy for Carcinoma of the Stomach in a Stand-alone Cancer Centre in Rural India.

Authors:  Nizamudheen Mangalasseri Pareekutty; Sachin Kadam; Basavaraj Ankalkoti; Satheesan Balasubramanian; Bindu Anilkumar
Journal:  Indian J Surg Oncol       Date:  2020-05-10

4.  A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes.

Authors:  Sharvesh Raj Seeruttun; Lipu Xu; Fangwei Wang; Xiaodong Yi; Cheng Fang; Zhimin Liu; Wei Wang; Zhiwei Zhou
Journal:  Cancer Commun (Lond)       Date:  2019-06-10

5.  Lymph Node Yield Following Packet Submission After Isolation By Surgeon During Gastrectomy.

Authors:  Pengpeng Wang; Kecheng Zhang; Hongqing Xi; Wenquan Liang; Tianyu Xie; Yunhe Gao; Bo Wei; Lin Chen
Journal:  Cancer Manag Res       Date:  2019-11-19       Impact factor: 3.989

6.  Clinicopathological Evaluation of Gastric Signet Ring Cell Carcinoma: Our Experience.

Authors:  Sevgi B Altay; Gökhan Akkurt; Nisbet Yılmaz; Nuriye Özdemir
Journal:  Euroasian J Hepatogastroenterol       Date:  2020 Jul-Dec

7.  The Prognostic Value of Lymph Node Ratio after Neoadjuvant Chemotherapy in Patients with Locally Advanced Gastric Adenocarcinoma.

Authors:  Kankai Zhu; Hailong Jin; Zhijian Li; Yuan Gao; Qing Zhang; Xiaosun Liu; Jiren Yu
Journal:  J Gastric Cancer       Date:  2021-03-24       Impact factor: 3.720

8.  Clinical impact of underutilization of adjuvant therapy in node positive gastric adenocarcinoma.

Authors:  Rebecca Zhu; Fangfang Liu; Gabriella Grisotti; Javier Perez-Irizarry; Ronald R Salem; Charles H Cha; Kimberly L Johung; Daniel J Boffa; Yawei Zhang; Sajid A Khan
Journal:  J Gastrointest Oncol       Date:  2018-06

Review 9.  Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan.

Authors:  Shuhei Komatsu; Eigo Otsuji
Journal:  Ann Gastroenterol Surg       Date:  2019-08-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.